APA (7th ed.) Citation

Kitay, A. M., Tillmann, A., Pfister, I., Schild, C., Bonanata, M., Heck, K., . . . Weinberger, A. (2026). One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. Ophthalmology & Therapy, 15(4), 1375. https://doi.org/10.1007/s40123-026-01344-x

Chicago Style (17th ed.) Citation

Kitay, Alice M., et al. "One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report." Ophthalmology & Therapy 15, no. 4 (2026): 1375. https://doi.org/10.1007/s40123-026-01344-x.

MLA (9th ed.) Citation

Kitay, Alice M., et al. "One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report." Ophthalmology & Therapy, vol. 15, no. 4, 2026, p. 1375, https://doi.org/10.1007/s40123-026-01344-x.